Simplifying oral solid dose manufacturing

Developing and manufacturing oral solid dose (OSD) therapies can require specialized expertise, and scalable manufacturing infrastructure. As pipelines span from standard tablets and capsules to increasingly include highly potent and complex compounds, selecting the right manufacturing approach becomes an important strategic decision.

This infographic highlights key considerations for navigating OSD manufacturing.

Download the infographic to explore:

Key capabilities needed to support OSD manufacturing
Technologies supporting highly potent and specialized OSD formulations
Considerations for scaling production from late-stage clinical to commercial supply
The role of global manufacturing networks and regulatory experience in supporting OSD programs

Powered by Pfizer expertise, Pfizer CentreOne brings decades of experience and specialized infrastructure designed to help pharmaceutical companies address their diverse OSD manufacturing needs.

Download the infographic to explore the capabilities and considerations shaping oral solid dose manufacturing today.

Pfizer CentreOne

Free Download

Fill out the form

Salutation First Name Last Name Email* Company Phone Department Position Street Zip City Country * Declaration of Consent

By completing this form to access the infographic , I understand my data will be shared with Pfizer CentreOne who may send me relevant updates and offers, and I can unsubscribe at any time via opt-out instructions in the emails. For more information on how your information will be used, please see the Privacy Policy.

Notes on data protection: Before receiving the infographic, you must register by providing your first and last name, your e-mail address, and possibly other data about yourself or your company. Please fill in the fields provided in the registration form.

Your data will be stored at B2B Expertise for the purpose of direct marketing and will be passed on to all affiliated companies of B2B Interactive GmbH as well as to our partner Pfizer CentreOne. For more information on the processing in our company, please refer to the B2B Interactive Privacy Policy.

You can revoke your consent at any time with effect for the future in writing by e-mail to the following address: info@b2binteractive.com (Subject: Pfizer CentreOne).